Screener
CorMedix CRMD Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| TOTAL ASSETS | $815,637 | $826,142 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $12,827 | $7,884 |
| Accrued expenses and other liabilities | 112,773 | 163,370 |
| Contingent Consideration, short-term | 3,176 | 3,015 |
| Total current liabilities | 128,776 | 174,269 |
| Convertible senior notes, net of deferred financing costs | 144,885 | 144,626 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's accounts payable?
- CorMedix (CRMD) reported accounts payable of $12.83M in Q1 2026.
- How has CorMedix's accounts payable changed year-over-year?
- CorMedix's accounts payable increased by 563.5% year-over-year, from $1.93M to $12.83M.
- What is the long-term trend for CorMedix's accounts payable?
- Over 5 years (2020 to 2025), CorMedix's accounts payable has grown at a 47.5% compound annual growth rate (CAGR), from $1.13M to $7.88M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about CorMedix's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude